Fasting plasma glucose 6–12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis

by Karl, D, Zhou, R, Vlajnic, A, Riddle, M
Published 2012

Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month ‘proof-of-concept’ s...

by Owens, D R, Luzio, S D, Sert-Langeron, C, Riddle, M C
Published 2011

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized c...

by Matsuhisa, M., Koyama, M., Cheng, X., Takahashi, Y., Riddle, M. C., Bolli, G. B., Hirose, T.
Published 2016

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycae...

by Terauchi, Y., Koyama, M., Cheng, X., Takahashi, Y., Riddle, M. C., Bolli, G. B., Hirose, T.
Published 2016

DGGE fingerprinting of bacteria in soils from eight ecologically different sites around Casey Station, Antarctica

by Chong, C.W., Tan, G.Y.A., Wong, R.C.S., Riddle, M.J., Tan, I.K.P.
Published 2009

Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study

by Rosenstock, J., Fonseca, V., McGill, J. B., Riddle, M., Hallé, J. P., Hramiak, I., Johnston, P., Davis, M.
Published 2009

Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label...

by Rosenstock, J., Fonseca, V., McGill, J. B., Riddle, M., Hallé, J.-P., Hramiak, I., Johnston, P., Davis, M.
Published 2009

New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)...

by Bolli, G B, Riddle, M C, Bergenstal, R M, Ziemen, M, Sestakauskas, K, Goyeau, H, Home, P D
Published 2015

One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insu...

by Riddle, M C, Yki-Järvinen, H, Bolli, G B, Ziemen, M, Muehlen-Bartmer, I, Cissokho, S, Home, P D
Published 2015

Fixed ratio dosing of pramlintide with regular insulin before a standard meal in patients with type 1 diabetes

by Riddle, M. C., Yuen, K. C. J., de Bruin, T. W., Herrmann, K., Xu, J., Öhman, P., Kolterman, O. G.
Published 2015

Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaem...

by Yki‐Järvinen, H., Bergenstal, R. M., Bolli, G. B., Ziemen, M., Wardecki, M., Muehlen‐Bartmer, I., Maroccia, M., Riddle, M. C.
Published 2015

Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naïve people with type 2 diabe...

by Home, P D, Bolli, G B, Mathieu, C, Deerochanawong, C, Landgraf, W, Candelas, C, Pilorget, V, Dain, M-P, Riddle, M C
Published 2015